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Background   It is unclear whether there is a clinical benefit to 
adding hydroxyapatite (HA) coatings to total knee implants, 
especially with the tibial component, where failure of the implant 
more often occurs. A systematic review of the literature was 
undertaken to identify all prospective randomized trials for 
determining whether the overall clinical results (as a function of 
durability, function, and adverse events) favored HA-coated tibial 
components. 
Methods   A comprehensive literature search was performed for 
the years 1990 to September 16, 2010. We restricted our search 
to randomized controlled trials involving participants receiving 
either an HA-coated tibia or other forms of tibial fixation. The 
primary outcome measures evaluated were durability, function, 
and acute adverse events. 
Results   Data from 926 evaluable primary total knee implants 
in 14 studies were analyzed. Using an RSA definition for dura-
bility, HA-coated tibial components (porous or press-fit) without 
screw fixation were less likely to be unstable at 2 years than porous 
and cemented metal-backed tibial components (RR = 0.58, 95% 
CI: 0.34–0.98; p = 0.04, I2 = 39%, M-H random effects model). 
There was no significant difference in durability, as measured 
from revision and evaluated at 2 and 8–10 years, between groups. 
Also, functional status using different validated measures showed 
no significant difference at 2 and 5 years, no matter what measure 
was used. Lastly, there was no significant difference in adverse 
events. Limitations included small numbers of evaluable patients 
(≤ 50) in 7 of the 14 trials identified, and a lack of “hard” evidence 
of durability with need for replacement (i.e. frank failure, pain, or 
loss of functionality). 
Interpretation   In patients > 65 years of age, an HA-coated 
tibial implant may provide better durability than other forms of 
tibial fixation. Larger trials should be undertaken comparing the 
long-term durability, function, and adverse events of HA-coated 
implants with those of other porous-coated tibial implants in 
younger, more active OA patients. 
 
Rationale
Experts have recommended that uncemented TKA is prefer-
able in patients < 60 years of age (Dorr 2002), for a number 
of reasons. Younger, more active patients can place higher 
stresses on implants and on their fixation to the bone. These 
higher stresses can result in osteolysis and loosening due to 
wear debris (including cement wear debris) generated over 
many years (Hoffmann et al. 2002). Considering that TKA 
implants last 10–15 years, the need for revision surgery and 
preservation of bone is of importance for younger patients. 
Uncemented implants may afford this.
The price of implants remains a major cost consideration 
for these types of procedures in the US. Hydroxyapatite 
(HA) coating on implants is usually an added cost (to an 
already expensive item) for providers, insurers, and patients. 
HA coatings may be applied to non-porous or porous sur-
faces. HA coatings are osteoconductive, meaning that they 
facilitate the formation of bone structure and may aid in 
more stable fixation over the years. Preclinical studies have 
shown that HA coatings can enhance the stability of implants 
by promoting early bone ingrowth even in the presence of 
interfacial gaps or initial interfacial instability (Dumbleton 
et al. 2004). HA-coated knee components have shown less 
radiolucency, with bone-filling gaps around the implant (Epi-
nette et al. 2004). Furthermore, up to 12-year follow-up of 
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of young, active patients has demonstrated excellent results 
(Tai and Cross 2006). Based on early findings, there may be 
clinical benefit to adding HA coatings to total knee implants, 
and most especially to tibial components, where failure of 
the implant more commonly occurs. However, no one has 
yet examined the highest-quality evidence in its entirety for 
these types of implants (i.e. evidence from prospective ran-
domized trials).
Objectives
We examined all the published prospective, randomized clini-
cal trials (level-1 evidence), comparing patients with OA who 
received HA-coated tibial components or other tibial designs 
including uncemented porous coated metal components, unce-
mented press-fit metal components, and cemented metal com-
ponents (porous and non-porous coated) to determine whether 
the clinical results of durability, function, and adverse events 
(both short and longer term) seen with HA-coated tibial com-
ponents were superior.
The following hypotheses were tested: 1. HA-coated tibial 
components as part of a total knee implant system have better 
durability than metal-backed (MB) tibial components (porous-
coated uncemented, press-fit uncemented, or cemented) irre-
spective of the manufacturer/brand and patient age at time of 
implant over the short term (2 years), and longer term (≥ 8 
years). 2. HA-coated tibial components as part of a total knee 
implant system have better functionality than MB tibial com-
ponents (porous-coated uncemented, press-fit uncemented, 
or metal-backed cemented) irrespective of the manufacturer/
brand and patient age at time of implant over the short term (2 
years) and longer term (≥ 8 years). 3. HA-coated tibial com-
ponents as part of a total knee implant system have a lower 
incidence of adverse events/complications than MB tibial 
components irrespective of the manufacturer/brand or method 
of fixation (e.g. cemented, porous coated). 
Methods
The Cochrane Review Manager software version 5.0.2 was 
used in assembling and reviewing the data (Cochrane 2008).
Protocol
A study protocol was not published prior to this analysis. How-
ever, the above hypotheses were developed a priori, i.e. before 
the results were available. These hypotheses were developed 
based on a previous current concept review (Dumbleton and 
Manley 2004) and on studies that have been published (not 
level-1 evidence) on the positive effect of HA coating on 
implant durability and function (Geekink et al. 1988, Rahbek 
et al. 2000, Dorr 2002, Dumbleton and Manley 2004, Akizuki 
et al. 2003, Kane et al. 2003, Epinette et al. 2004, Rahbek et 
al. 2005, Tai and Cross 2006). 
Eligibility criteria for considering studies for this review
Types of studies. Randomized controlled trials (RCTs) were 
eligible for inclusion if they compared the use of an HA-
coated tibial component and any other metal-backed tibial 
component in the short and longer term, specifically exam-
ining the durability (length of time the implant survived in 
the patient without having to perform a repeat procedure for 
loosening or pain or loss of function—i.e. revision surgery), 
functionality and pain (using validated scoring systems such 
as the Knee Society score, HHS, WOMAC (SF-36), LEFS), 
and adverse events.
Durability and/or functionality (as defined below) must 
have been one of the primary outcome measures evaluated in 
the trial. 
Definitions used for eligibility criteria. The following defi-
nitions were used to determine clinical outcomes: durability, 
function, and adverse events. The definitions below are consis-
tent with other technology assessments in total knee replace-
ment (Kane et al. 2003) and with the widely used maximum 
total point motion analysis as defined by Ryd et al. (1995).
Durability was defined as the quality of fixation of the tibial 
component using radiographic analysis, or the length of time 
a total knee implant survives in a patient without having to 
replace it due to loosening/instability, wear, pain, or loss of 
functionality. Longitudinal radiographic analysis has been 
used increasingly over time as an accurate tool for assessment 
of micromotion in orthopedic implants, and is highly predic-
tive of clinical loosening and revision (Ryd et al. 1995), espe-
cially when measured relatively early in the life of the implant 
(after 1–2 years). It has been found that continuous compo-
nent migration represents defective fixation that shows very 
early. A maximum total point motion (MTPM) of > 0.2 mm/2 
years implies that revision due to loosening can be predicted. 
(MTPM is a 3-dimensional vector, with the vectors being: (1) 
the x plane, which corresponds to medial migration of the 
component; (2) the y plane, which corresponds to proximal 
migration; and (3) the z plane, which corresponds to posterior 
migration). Thus, length of time in years that a tibial implant 
survives without having to replace it, or MPTM > 0.2 mm/2 
years was used to define durability (indicating implant would 
likely fail).
Functionality was defined as the ability of the recipient of a 
total knee implant to function (including toleration of pain) in 
everyday living, as measured by a number of validated scor-
ing systems including: the Knee Society score, Hospital for 
Special Surgery score (HSS) (Insall et al. 1976), the Western 
Ontario and McMaster University arthritis index (WOMAC), 
the SF-36/SF-12 health survey, the Oxford knee score, the 
EuroQol-5D, and the lower extremity functional scale (LEFS). 
In all measures, the higher the score, the better the patient is 
regarding clinical and functional outcome. The Knee Society 
score (KSS) is a tool for assessing a patient’s: pain, flexion 
(range of motion), and knee alignment and function (walking 
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is a surgeon-assessed, variable weighted score which results 
in a “clinical” score for the patient. The HSS score is also a 
surgeon’s assessment of a patient’s pain, range of motion/flex-
ion, function, knee alignment, stability, and need for walking 
aids. The WOMAC index (a patient-assessed index) is used to 
assess patients with osteoarthritis of the knee using 24 param-
eters, and it focuses on pain, stiffness, and social and emo-
tional function. The SF-36 health survey (patient-assessed) 
yields a profile of functional health and well-being scores as 
well as a psychometrically-based health utility index. It is a 
general measure and does not target any specific age, disease, 
or treatment group. A shorter version of the SF-36, the SF-12 
form, is also used for functionality. The Oxford knee score 
(OKS) is a patient-assessed equally weighted score. The OKS 
assesses pain and function from the patient’s point of view. 
The higher the score, the more “functional” a patient is. The 
EuroQol-5D is a standardized instrument for use as a mea-
sure of health outcome. It is designed to assess a wide variety 
of health conditions and treatments, and provides a simple 
descriptive profile and a single index value for health status. 
It is designed for self-completion. EuroQol-5D consists of 5 
dimensions: mobility, self-care, usual activity, pain/discom-
fort, and anxiety/depression. The LEFS (also developed at 
MacMaster University) measures the functional effectiveness 
of an intervention over time (also patient-assessed).
Adverse events were defined as complications resulting from 
the surgical procedure and/or subsequent need for surgical 
intervention and included: DVT, instability due to late varus 
or valgus with need for surgical intervention, patellofemoral 
problems with need for surgical intervention, knee flexion 
problems (including stiffness) with need for surgical manipu-
lation, hematoma requiring evacuation, allergic reactions to 
medications and infections (over the life of the implant).
Types of participants. Any person undergoing a first-time 
total knee arthroplasty.
Interventions: Patient of any age undergoing a total knee 
implant that contained an HA-coated tibial component vs. 
other total knee implant with a different mode of fixation of 
the tibial component. Comparison groups in prospective ran-
domized trials included:
•	 Total	knee	implant	with	HA-coated	tibial	component	(with	or	
without porous coated tibial undersurface; and with or without 
screw fixation) compared to a total knee implant with porous 
coated or press-fit stemmed metal tibial tray with polyethylene 
bearing surface.
•	 Total	knee	implant	with	HA-coated	tibial	component	(with	or	
without porous coated tibial undersurface; and with or without 
screw fixation) compared to a total knee implant with porous 
coated modular (for polyethylene insert) metal tibial tray with 
polyethylene bearing surface; with or without screw fixation.
•	Total	knee	implant	with	HA-coated	tibial	component	(with	or	
without porous coated tibial undersurface; and with or without 
screw fixation) compared to a total knee implant with a cemen-
ted metal tibial tray with polyethylene insert bearing surface.
Types of outcome measures 
•	 Durability	of	implant	with	at	least	2-year	follow-up	(including	
availability of MTPM or radiographs at 2 years).
•	 Functionality	of	implant	with	at	least	2-year	follow-up.
•	 Adverse	 events	 occurring	 during	 procedure	 or	 afterwards,	
such as deep vein thrombosis, allergic reactions, infections, 
decreased range of motion.
Secondary outcomes 
•	Osteoarthritis	vs.	rheumatoid	arthritis	patients	(HA	vs.	other	
tibial fixation) and comparing above primary outcomes.
•	Cost-effectiveness	analysis.
Search methods for identification of studies
Electronic and other searches (See Appendix 1 – Supplemen-
tary data)
Data collection and analysis
Selection of studies: Both authors screened the titles and 
abstracts of all studies identified in the search strategy. Full 
text versions were obtained of all studies identified as being 
potentially relevant, and were assessed for inclusion, using an 
eligibility pro forma screening document that was based on 
pre-specified inclusion/exclusion criteria.
Data extraction and management: A data extraction form 
was developed to aid in the collection of details (data items) 
from included studies. One review author (JDV) indepen-
dently extracted the data, and a second review author (MM) 
validated the extracted data. Appendix 2 – Supplementary data 
shows this form.
If more than one publication arose from the same study, all 
versions were considered to maximize data extraction and the 
primary publication was identified along with the secondary 
references.
Assessment of risk of bias in included studies
Studies were assessed using the Cochrane Collaboration tool 
for assessing risk of bias—at both the study level and the out-
come level (Higgins et al. 2008). This tool addresses 6 specific 
domains, namely sequence generation, allocation conceal-
ment, blinding, incomplete outcome data, selective outcome 
reporting and other issues (e.g. extreme baseline imbalance) 
(see Appendix 3 – Supplementary data for details of criteria 
on which the bias judgment was based). Blinding and com-
pleteness of outcome data were assessed for each outcome 
separately. A risk-of-bias table was completed for each eli-
gible study. Any disagreement among the review authors was 
discussed to achieve a consensus.
An assessment of risk of bias using a “risk of bias sum-
mary figure”, which presents all of the judgments in a cross-
tabulation of studies by entry was evaluated. This display of 
internal validity indicates the weight the reader may give the 
results of each study.
Studies other than RCTs (i.e. quasi-randomized controlled 
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rated the results of the risk-of-bias assessment into the review 
through systematic narrative description and commentary 
about each of the domains, leading to an overall assessment of 
the risk of bias of included studies and a judgment about the 
internal validity of the results.
Measures of treatment effect 
Each study is reported separately. The results of binary out-
comes (e.g. revision or not) are presented as risk ratios (RRs) 
with corresponding 95% confidence intervals (CIs). For con-
tinuous data, we used the mean difference if outcomes were 
measured in the same way between trials. Furthermore, if 
pooling of data was not possible, we used the statistics used 
in the study for analysis of treatment effect; in most cases the 
Mann-Whitney U test was used (a nonparametric test).
Dealing with missing data 
In such cases, we attempted to contact authors where data was 
missing and requested it. We also addressed the effect of miss-
ing data in the discussion section. In the case of abstracts, we 
attempted to contact authors to determine whether a paper had 
been published in a peer-reviewed journal. If a paper had been 
written from an abstract but was unpublished, we attempted to 
obtain it from the authors.
Assessment of heterogeneity 
Assessment of statistical heterogeneity was done using the I2 
statistic, in order to determine appropriateness for meta-anal-
ysis. If the I2  statistic was at or below 60%, the heterogeneity 
was considered moderate and meta-analysis was considered 
appropriate. If the value was greater than 60%, sensitivity 
analysis was undertaken in an attempt to identify which stud-
ies were most likely to be causing the problem. If there were 
only a few such studies, and they could be identified, the rea-
sons for their difference were explored and the appropriateness 
of removing these studies was determined. When appropriate, 
meta-analysis excluding any such studies was performed.
Assessment of reporting biases 
We used a funnel plot to assess reporting bias. Each primary 
outcome was reported separately. Furthermore, an assessment 
was made of publication bias (including a review of unpub-
lished studies), location bias (types of journals), and language 
bias. 
Data synthesis 
Where possible, we grouped studies together that were similar. 
In the absence of heterogeneity (I2 = 0%) or in the presence of 
low heterogeneity (I2 statistic less than 40%), a fixed-effects 
model was used. If heterogeneity was moderate (I2 statistic 
greater than 40% and less than or equal to 60%), a random-
effects model was used.
 
Results
Results of the search: 19 studies were identified for evaluation 
(see also the PRISMA flow diagram; Figure 1). 
Included studies
We identified 14 prospective randomized trials in which a total 
knee implant with an HA-coated tibial component was com-
pared to: cemented non-porous coated stemmed metal tibial 
tray with polyethylene insert bearing surface; porous coated 
metal-backed tray with polyethylene insert bearing surface 
(non-cemented); and porous coated metal-backed tray with 
screw fixation and polyethylene insert bearing surface (non-
cemented). No studies were identified that compared an HA-
coated tibial component to a cemented all-polyethylene tibial 
component. This included a total of 926 evaluable total knee 
implants (Table 1).
Based on the available data, the comparisons evaluated were 
as follows:
•		HA-coated	 (with	 or	 without	 porous	 coated	 tibial	 undersur-
face and with or without screw fixation) vs. all other implants 
(cemented MB and porous-coated MB with or without screw 
fixation). Evaluation of performance against the RSA (MPTM) 
endpoint was done at 2 years (Regnér et al. 1998, Nilsson et al. 
1999, 2006, Toksvig-Larsen et al. 2000, Carlsson et al. 2005, 
Hansson et al. 2008, Pijls et al. 2010)
Figure 1. PRISMA 2009 flow diagram used to identify studies for inclu-
sion in HA tibial analysis. 
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•	 HA-coated	(with	or	without	porous	coated	tibial	undersurface	
and without screw fixation) vs. other implants (cemented MB 
and porous coated MB without screw fixation). Evaluation of 
performance against the RSA (MPTM) endpoint was done at 
2 years (Toksvig-Larsen et al. 2000, Nilsson et al. 1999, 2006, 
Carlsson et al. 2005, Hansson et al. 2008)
•	 HA-coated	(with	or	without	porous	coated	tibial	undersurface	
and without screw fixation) vs. porous coated MB without 
screw fixation). Evaluation of performance against the RSA 
(MPTM) endpoint was done at 2 years (Toksvig-Larsen 2000, 
Hansson et al. 2008) 
•	 HA-coated	(with	or	without	porous	coated	tibial	undersurface	
and without screw fixation) vs. cemented MB. Evaluation of 
performance against the RSA (MPTM) endpoint was done at 2 
years (Nilsson et al. 1999, 2006, Carlsson et al. 2005)
•	 HA-coated	(with	porous	coated	tibial	undersurface	and	with	
screw fixation) vs. porous coated MB with screw fixation). 
Evaluation of performance against the RSA (MPTM) endpoint 
was done at 2 years (Regnér et al. 1998). 
•	 HA-coated	vs.	cemented	MB	tibia	–	durability	(failure	requi-
ring a revision) at 5 years (Nilsson et al. 1999, Carlsson et al. 
2005, Beaupré et al. 2007) 
•	 HA-coated	vs.	cemented	MB	tibia	–	durability	(failure	requi-
ring a revision) at 8–10 years (Findlay et al. 2007, Pijls et al. 
2010) 
•	Functional	assessment:
   – KSS clinical score at 2 years (Carlsson et al. 2005)—compa-
ring HA separately to cemented and porous or press-fit.
    – HSS score at 2 years (Regnér et al. 1998, van der Linde 2008). 
•	RAND-36	and	WOMAC	at	5	years
•	HA-coated	vs.	cemented	implants—adverse	events	(Nilsson	et	
al. 1999, 2006, Carlsson et al. 2005, Beaupré et al. 2007, Find-
lay et al. 2007, Pijls et al. 2010). 
See Appendix 4 – Supplementary data for characteristics of 
studies included.
Excluded studies
Two trials were excluded, as they were earlier trials (Önsten 
et al. 1998, Nelissen et al. 1998) Önsten et al. (1998) was 
an earlier trial of Carlsson et al. (2005). Note, however, that 
Önsten et al. (1998) was used for adverse event/complication 
data, KSS scores, and for randomization scheme. Nelissen et 
al. (1998) was an earlier trial of Pijls et al. (2010). Note, how-
ever, that Nelissen et al. (1998) was used for adverse events, 
KSS functional scores, and for randomization scheme. One 
study was excluded (Therbo et al. 2008) due to fact that it did 
not meet the criteria for inclusion—i.e. it only had one year 
follow up. One was excluded (Nakama et al. 2006) as it was 
a protocol only, and 1 was excluded (Uvehammer et al. 2007) 
because it analyzed the femoral component only. Thus, 5 stud-
ies were excluded. 
Risk of bias in included studies
Allocation. Sequence generation (randomization scheme 
used) and allocation to treatment arm were not well defined in 
the majority of the studies.
Blinding. Physicians performing the procedure could not be 
blinded regarding the treatment arm. In a number of the stud-
ies, it was unclear whether patients had also been blinded to 
the treatment arm. It was also unclear in approximately 50% 
of the studies whether clinicians evaluating radiographs over 
time (for potential loosening of the implant) were blinded to 
the treatment arm. In addition, it was unclear approximately 
50% of the time whether clinicians evaluating for function-
ality, pain, and quality of life were blinded to the treatment 
arm.
Incomplete outcome data: A substantial proportion of the 
missing data, especially in the longer-term outcome studies, 
were related to survival of the patient. According to the appen-
dix “risk of bias assessment”, this represents a low risk of bias.
Overall assessment of reporting bias—funnel plot 
analysis (not shown)
Durability as measured by RSA with MPTM of > 0.2 mm/2 
years constituting instability: Funnel plot analysis of this out-
come for the 7 studies included (Regnér et al. 1998, Nilsson 
et al. 1999, 2006, Toksvig-Larsen 2000, Carlsson et al. 2005, 
Hansson et al. 2008, Pijls et al. 2010) showed symmetry, indi-
cating that bias was minimal. All other subsets/permutations 
of this also showed symmetry. 
Durability as defined by need for revision at 5 years: Funnel 
plot analysis of this outcome for the 3 studies included (Nils-
son et al. 1999, Carlsson et al. 2005, Beaupré et al. 2007) 
showed symmetry, indicating that bias was minimal. 
Durability as defined by need for revision at 8–10 years: 
Funnel plot analysis of this outcome for the 2 studies included 
(Findlay et al. 2007, Pijls et al. 2010) showed symmetry, indi-
cating that bias was minimal. 
Adverse events: Funnel plot analysis of this outcome for 
the 6 studies included showed symmetry, indicating that bias 
Table 1. The number of evaluable knees used from each trial and 
included in outcome analysis
Study  No. of  HA  Other  Country 
  knees  group group
Beaupré 2007  81  40  41  Canada
Carlsson 2005  150  50  100  Sweden
Findlay 2007  171  94  77  UK
Hansson 2008  49  24  25  Sweden
Nilsson 1999  57  29  28  Sweden
Nilsson 2006  95  62  33  Sweden
Petersen 2005  16  8  8  Denmark
Pijls 2010  29  9  20  Netherlands
Regnér 1998  40  20  20  Sweden
Regnér 2000  51  25  26  Sweden
Toksvig-Larsen 2000  47  28  19  Sweden
van der Linde 2006  22  12  10  Netherlands
van der Linde 2008  78  38  40  Netherlands
Walker 2000  40  12  28  UK
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was minimal (Nilsson et al. 1999, 2006, Carlsson et al. 2005, 
Beaupré et al. 2007, Findlay et al. 2007, Pijls et al. 2010).
Effects of interventions 
The results of each comparison category are shown in Table 
2, Figures 2 and 3). We considered the definition of durabil-
ity (mainly RSA analysis) to be consistent enough to warrant 
pooling of data. Secondly, we also accepted that there was 
variation in the reported definition of adverse events (a second 
main outcome measure) but we attempted to standardize this 
definition by not including adverse events that appeared not 
to result from complications arising from the surgery itself or 
from the function of the tibial implant. Examples of exclu-
sions included: partial tear of the quadriceps tendon, patel-
lar fracture following a fall, fracture of the femoral neck, and 
ipsalateral patellar fracture following a car accident. In all of 
these trials, the evaluation of heterogeneity was low to moder-
ate. Lastly, we realized that there was probably wide variation 
in the functional assessment based on the various validated 
measures used, and attempted to pool data where the same 
validated measure was used.   
Other durability data examined—non-pooled
In a separate trial examining the changes in bone mineral den-
sity using DEXA analysis between HA-coated (n = 8) and 
porous coated tibial implants (n = 8), Peterson et al. (2005) 
found no significant effect of HA coating on bone remodeling 
in the proximal tibia.
Durability as defined above by Ryd et al. (1995) (MTPM of 
> 0.2 mm in 2 years for prediction of loosening at 10 years) 
or abject failure could not be examined in the paper by Walker 
et al. (2000), as the analyses performed in this trial examined 
migration in the implant groups only (HA press-fit vs. MB 
press-fit vs. MB cemented) and did not define failure based 
on the definition by Ryd et al. (1995). What was found was 
that migration based on the Walker definition was statistically 
significantly higher in the MB press-fit group than in the HA 
press-fit or MB cemented groups when examined for axial 
migration (p-values not stated). Furthermore, tilt angles about 
the M-L axis were statistically significantly different between 
MB cemented and MB press-fit (favoring less migration with 
MB cemented at 19–30 months postoperatively). There was 
no statistically significant difference in this parameter between 
MB press-fit and HA press-fit.
Comparisons made Trials included Endpoint HA 
pooled 
sample 
size
MB 
pooled 
sample 
size
RR (95% CI) Model used
HA coated (with and without porous 
coated tibial undersurface) with and 
without screw fixation vs. MB cemented 
and porous coated tibial components 
with and without screw fixation (see 
Figure 2)
Regnér et al. 1998, 
Nilsson et al. 1999, 
Toksvig-Larsen et al. 
2000, Carlsson et al. 
2005, Nilsson et al. 
2006, Hansson et al.  
2008, Pijls et al. 2010
MTPM >0.2 
mm/2 years
197 147 RR=0.63 
(0.36–1.11); 
p=0.11; 
I2 = 50%
M-H random 
effects 
HA coated (with and without porous 
coated tibial undersurface) without 
screw fixation vs. MB cemented and 
porous coated tibial components with-
out screw fixation (see Figure 3)
Nilsson et al. 1999, 
Toksvig-Larsen et al. 
2000, Carlsson  et al. 
2005, Nilsson et al. 
2006, Hansson et al. 
2008 
MTPM >0.2 
mm/2 years
149 139 RR=0.58 
(0.34–0.98); 
p=0.04, 
I2 = 39%
M-H random 
effects
HA coated (with and without porous 
coated tibial undersurface) without 
screw fixation vs. MB porous coated 
components without screw fixation 
(figure not shown)
Toksvig-Larsen et al. 
2000, Hansson et al. 
2008 
MTPM >0.2 
mm/2 years
52 44 RR=0.16 
(0.00–5.75);
p=0.32; 
I2 = 84%
M-H random 
effects 
HA coated (with and without porous 
coated tibial undersurface) without 
screw fixation vs. cemented MB tibial 
components (figure not shown)
Nilsson et al.  1999, 
Carlsson  et al. 2005, 
Nilsson et al. 2006
MTPM >0.2 
mm/2 years
97 85 RR=0.65
(0.41–1.04); 
p=0.07; 
I2 = 29%
M-H fixed 
effects
HA coated (with and without porous 
coated tibial undersurface) vs. 
cemented MB tibial components (figure 
not shown)
Nilsson et al. 1999, 
Carlsson et al. 2005, 
Beaupré et al. 2007 
5 year dura-
bility – need 
for replace-
ment
97 87 RR=1.83 
(0.34–9.86); 
p=0.48; 
I2 = 0%
M-H fixed 
effects
HA coated (with and without porous 
coated tibial undersurface) vs. 
cemented MB component (figure not 
shown)
Findlay et al. 2007, 
Pijls et al. 2010
8–10 year 
period – 
need for 
replacement
104 88 RR=3.28
(0.37–28.7); 
p=0.28; 
I2 = not applicable
M-H fixed 
effects
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Durability as defined by Ryd et al. (1995) (MTPM of > 0.2 
mm in 2 years for prediction of loosening at 10 years) or 
abject failure could not be examined in the paper by van der 
Linde et al. (2008) paper, as the analysis performed used the 
above criterion for prediction of loosening at 10 years. Using 
this definition, 11 tibial trays from the periapatite (PA) group 
(26%) and 29 tibial trays from the porous group (63%) could 
be identified as being at risk of loosening at 10 years. There 
was no statistical analysis performed with this finding. In addi-
tion, in this paper the authors did not identify any implants that 
required revision.
 
Function
Function was evaluated using validated scoring systems as 
outlined above. Functional scores were reported on below 
from data at 2 years and 5 years (Table 3).
Other functional data examined
The functional status (as assessed using the KSS) of Walker et 
al. (2000) was evaluated based on data presented in the trial, 
which demonstrated no statistically significant difference 
between the groups from the KSS score at 2 years (p-values not 
available) (HA press-fit vs. MB press-fit vs. MB cemented). 
Adverse events
Data concerning 586 knees were pooled from 6 trials (Nilsson 
et al. 1999, 2006, Carlsson et al. 2005, Beaupré et al. 2007, 
Findlay et al. 2007, Pijls et al. 2010) analyzing adverse events. 
Adverse events were defined as complications resulting from 
the surgical procedure and/or subsequent need for surgical 
intervention or immediate medical attention, and included: 
DVT, instability due to late varus or valgus with need of 
surgical intervention, patellofemoral problems with need of 
surgical intervention, knee flexion problems (including stiff-
ness) with need of surgical manipulation, hematoma requiring 
evacuation, allergic reactions to medications and infections 
(over the life of the implant). Adverse events were not sig-
nificantly different between the groups (RR = 1.20, 95% CI: 
0.63–2.28; p = 0.58; I2  = 0%; Mantel-Haenszel (M-H) fixed-
effects model) (Figure 4). 
Risk of bias across studies
All studies identified had been published in English. However, 
as noted above in the funnel plot analyses for overall assess-
ment of reporting bias, symmetry was noted, indicating low 
expectation of reporting bias. Furthermore, in half of the stud-
ies identified there were low numbers of patients (≤ 50).
Figure 2. RSA analysis year 2; HA-coated vs. other tibial fixation; all implants. 
Figure 3. RSA analysis year 2; HA-coated vs. other tibial fixation; all implants except for those with screw fixation of tibial baseplate. Acta Orthopaedica 2011; 82 (4): 448–459  455
Additional analysis
All of these studies were conducted outside the US, with 7 
of the 14 from Sweden, 1 from Denmark, 3 from the Nether-
lands, 2 from the UK, and 1 from Canada.
The majority of patients enrolled in the trials were 67–70 
years of age. Only 3 trials evaluated patients < 65 years of age 
(Walker et al. 2000, Nilsson et al. 2006, Beaupré et al. 2007). 
These studies could not be combined on the durability endpoint 
due to the fact that different endpoints were analyzed (Beaupré 
et al. (2007) had a primary endpoint of durability (revision) at 5 
years; Nilsson et al. (2006) had a primary endpoint of durabil-
ity (MPTM > 0.2 mm in 2 years), and Walker et al. (2000) had 
a primary endpoint of functional status measured with KSS 
only, and there was insufficient data available).
Discussion
Durability
The results show that there is likely a benefit in reducing the 
incidence of instability, and hence a need for revision later 
in the implant life (as measured by MPTM analysis) between 
the first and second year with HA-coated tibial implants as 
opposed to all other types of tibial implants when used in 
patients requiring primary total knee replacement. It should be 
noted that in the analysis of MPTM, a strict definition of > 0.2 
mm in 2 years was used, according to Ryd et al. (1995). How-
ever, in one of the trials (Pijls et al. 2010), a definition of “tibial 
at-risk loosening” of MPTM ≥ 0.2 mm in 2 years was used. 
If this trial is included in the analysis of HA-coated implants 
without screw fixation vs. other tibial fixation without screw 
Figure 4. Adverse events; complications resulting from the surgical procedure and/or subsequent need for surgical intervention or immediate 
medical attention.
Comparisons made Trials included Endpoint HA 
sample 
size
MB 
sample 
size
Difference
mean (95% Ci)
p-value
HA coated (porous & press fit) vs. 
porous MB tibial components
Carlsson et al. 
2005
Knee Society Score 
clinical assessment – 2 
year 
50 37  1.00 (-3.63 to 5.63) 0.67
HA coated with porous coated tibial 
undersurface vs. cemented MB tibial 
components
Carlsson et al. 
2005
Knee Society Score 
clinical assessment – 2 
year
50 29  3.00 (-4.35 to 10.35) 0.42
HA coated with porous coated tibial 
undersurface with screw fixation vs. 
porous MB tibial components with 
screw fixation
Regnér et al. 
1998
Hospital for Special 
Surgery (HSS) clinical 
assessment – 2 year
20 20 -1.00 (-3.60 to 5.66)  0.67
HA coated with porous coated tibial 
undersurface without screw fixation 
vs. porous MB tibial components 
without screw fixation
van der Linde 
et al. 2008
Hospital for Special 
Surgery (HSS) clinical 
assessment – 2 year
38 48  0.00 (-3.86 to 3.86)  1.00
HA coated press fit vs. cemented MB 
tibial component
Beaupré et al. 
2007
RAND-35 at 5 years 40 41  3.46 (-8.23 to 15.15) 0.56
HA coated press fit vs. cemented MB 
tibial component 
Beaupré et al. 
2007
WOMAC at 5 years 40 41 -1.40 ( -10.36 to 7.56)  0.76
Table 3. Function scores from data at 2 years and 5 years. Statistical method used:  Inverse variance, fixed effects analysis model456  Acta Orthopaedica 2011; 82 (4): 448–459
fixation, the impact of HA coatings on reducing micromo-
tion is strengthened further (RR = 0.62, 95% CI: 0.40–0.96; 
p = 0.03; I2  = 27%; M-H random-effects model) (Figure 5). 
HA coatings might provide a “biological seal”, preventing the 
migration of wear debris (i.e. polyethylene, metal) even under 
unstable conditions (e.g. excessive micromotion) (Rahbek et 
al. 2000, 2001, 2005).
As mentioned above, when those HA implants with screw 
fixation were excluded from the analysis (Regnér et al. 1998, 
Nilsson et al. 2006), a statistically significant result was noted 
in favor of HA-coated implants. Possible reasons for the 
instability experienced with the screw-fixated HA tibial com-
ponents as noted in other studies might be screw osteolysis 
(Peters et al. 1992, Gejo et al. 2002) from wear debris gener-
ated through movement of the tibial insert within the metal-
backed tibial component and/or wear debris generated from 
micromotion at; the screw head/tibial baseplate interface. In 
any case, screwless fixation of the HA tibial baseplate proved 
to be superior. The HA coating used in those trials that could 
be combined for meta-analyses purposes and which proved 
to be superior (i.e. more stable) was in the thickness range 
of 30–60 μm with a porous coated pore size in the range of 
150–425 μm (Toksvig-Larsen et al. 2000, Carlsson et al. 2005, 
Nilsson et al. 2006, Hansson et al. 2008). This was in the range 
of the specifications according to the manufacturer, and was in 
the thickness range for providing better strength than thicker 
coatings (Dumbleton et al. 2004). It should also be noted that 
thicker HA coatings had a tendency to fatigue when placed 
under load in the laboratory (Dumbleton et al. 2004), and also 
that in the trial by Regnér et al. (1998), the HA thickness was 
noted to be in the 80–130 μm range. Possibly the thickness of 
the HA coating in this trial contributed to instability due to 
fatigue.
As Ryd et al. (1995) stated above, continuous migration 
represents defective fixation that manifests very early, and is 
highly predictive of clinical loosening and revision at year 10. 
Concerning the outcome of durability as measured by failure 
at 2 years (requiring revision), there was found to be no dif-
ference between HA-coated and cemented MB tibial com-
ponents. While the trial by Walker et al. (2000) did not use 
an endpoint that was similar to the others (i.e. MTPM > 0.2 
in 2 years), it did demonstrate that the use of HA coating on 
a press-fit metal-backed implant provided significantly less 
micromotion than a press-fit metal-backed implant only. This 
further supports the notion that HA coating alone provides 
better fixation than implants that are not HA-coated (albeit 
MB press-fit). 
The trial by van der Linde et al. (2008) deviated from the 
more common endpoint used to determine longer-term dura-
bility (i.e. MTPM > 0.2 mm in 2 years). Instead, it used a 
definition of MTPM > 0.5 mm in 2 years in predicting which 
implants would be considered loose at 10 years. In using 
this definition, HA coating added to the porous coated tibial 
undersurface demonstrated improved fixation compared to a 
metal-backed porous coated undersurface (p = 0.047). This 
further supports the notion that HA provides improved fixa-
tion over porous coated implants. It is unclear why the authors 
of this article chose to deviate from the definition by Ryd et al. 
(1995), and despite repeated attempts to contact the author for 
an explanation, we did not receive a reply. 
Functionality
As it relates physician- and patient-assessed functioning, there 
appeared to be no clinically meaningful difference in mean 
KSS, HSS, WOMAC, and RAND-36 between HA-coated and 
other tibial implants. One of the issues with the data available 
was that a pre- and postoperative (2- and 5-year) analysis could 
not be performed. The only analysis that could be undertaken 
was to examine a difference between groups regarding func-
tion at 2 and 5 years, which again demonstrated no difference.
Limitations, and other observations
Due to the limited numbers of patients, recommendations on 
the applicability of the evidence cannot be made with com-
Figure 5. RSA analysis year 2; HA-coated vs. other tibial fixation; all implants except for those with screw fixation of tibial baseplate using an 
expanded definition of MPTM ≥ 0.2 mm in 2 years. Acta Orthopaedica 2011; 82 (4): 448–459  457
plete confidence. In a prior analysis on small study effects in 
meta-analysis of osteoarthristis trials (a meta-epidemiological 
study), it was determined that on average, treatment effects 
were more beneficial in small trials (< 100) than in large trials 
(> 100)—leading to a distortion of the results in meta-analyses 
(Nüesch et al. 2010). It further recommended that the influ-
ence of small trials on estimated effects should be routinely 
assessed. The Cochrane Handbook for Systematic Reviews of 
Interventions has recommended the following when evaluat-
ing treatment effects of small-size studies: “We recommend 
that when review authors are concerned about the influence 
of small-study effects on the results of a meta-analysis in 
which there is evidence of between-study heterogeneity (I2  
> 0), they compare the fixed- and random-effects estimates 
of the intervention effect. If the estimates are similar, then 
any small-study effects have little effect on the intervention 
effect estimate. If the random-effects estimate is more ben-
eficial, review authors should consider whether it is reason-
able to conclude that the intervention was more effective in 
the smaller studies.” This analysis was performed, and demon-
strated similarity in the intervention effect shown in Figure 3 
below (random-effects model: RR = 0.58, 95% CI: 0.34–0.98; 
p=0.04; I2  = 39%; vs. fixed-effects model: RR = 0.53, 955, 
CI: 0.36–0.77; p < 0.001; I2  = 39%). Thus, it does appear that 
HA coating (especially without screw fixation) may promote 
early fixation/stability compared to other tibial components 
(cemented and porous coated) in younger patients, as assessed 
by MPTM at 2 years. The main concern is that there is limited 
long-term evidence regarding “hard” durability (need for revi-
sion/replacement). The functioning of patients with HA coat-
ings appears to be comparable to that with other implant types 
at 2 and 5 years, regardless of the measure. Adverse events 
were similar between HA coatings and other implant types.
The trials evaluated in this meta-analysis were performed 
mainly on patients with osteoarthritis, with a very small minor-
ity in patients with rheumatoid arthritis. Nilsson et al. (1999) 
had 12 patients with RA out of 53; Nilsson et al. (2006) had 
23 patients with RA out of 85; and Pijls et al. (2010) had 26 
patients with RA and 6 with OA). Unfortunately, none of these 
patients could be evaluated by outcome as described above 
to determine whether RA patients with HA-coated implants 
fared better regarding outcome than those with other types 
of tibial fixation (as RA patients were not specifically evalu-
ated on the outcomes of durability, functionality, and adverse 
events).
Cost-effectiveness analysis
There were no studies that compared the cost effectiveness of 
HA-coated tibial components with that of any other method of 
tibial fixation. In the trials that examined patients < 65 years of 
age, the endpoints varied between studies and further analysis 
could not be undertaken by combining studies. 
The overall quality of the evidence can be considered “aver-
age”. It was not possible to blind the clinician performing 
the procedure. Blinding of patients, of clinicians assessing 
RSA, and of clinicians evaluating function was not clear in 
most studies. Also, the randomization method used in allocat-
ing patients to treatment groups was not clear in the major-
Figure 7. Review of authors’ judgments about each risk of bias item for 
each study included.
Figure 6. Risk-of-bias graph summary – review of authors’ judgments 
about each risk-of-bias item presented as percentages across all the 
studies included.458  Acta Orthopaedica 2011; 82 (4): 448–459
ity of the studies. Most results (including missing data) were 
accounted for. Most clinicians performing the trials were 
funded from outside sources, either industry, medical associa-
tions, or foundations. (See Figures 6 and 7 for summary of 
risk-of-bias assessment).
While no studies were identified in non-English peer-
reviewed literature, these studies may exist and were not part 
of this analysis. However, total joint arthroplasty is practiced 
mainly in English-speaking countries; thus, is it likely that the 
majority of studies were identified and analyzed.
Authors’ conclusions 
These findings indicate that longer-term durability may be 
enhanced with HA-coated implants, in patients who are < 
70 years of age. Furthermore, it appears that functionality as 
measured by various validated scoring systems appears to be 
no different between HA-coated and other tibial implant com-
ponent types at 2 and 5 years. Thus, in patients who fall within 
the 65–70 age group, HA coating may be of benefit. Unce-
mented HA-coated tibial implants may be of use in younger 
more mobile patients, who may require a second knee implant 
(revision) later on in life. 
Larger-sized studies (i.e. with > 100 patients) should be 
undertaken to compare the longer-term durability (as mea-
sured by need of revision), function, and adverse events with 
HA-coated implants vs. other porous coated tibial implants in 
much younger, more active patients (< 65 years of age); dura-
bility in patients aged < 65 years (as measured by RSA); and 
outcome of HA-coated implants in patients with RA. 
JV and MM developed the hypotheses. JV and MM screened the titles and 
abstracts of all studies identified in the search strategy. JV obtained full-text 
versions of all studies identified as being potentially relevant, and assessed 
them for inclusion using an eligibility pro forma screening document that was 
based on pre-specified inclusion/exclusion criteria. MM then reviewed these 
studies independently. Disagreements were resolved by discussion or adjudi-
cated by an independent third party. The drafts of the manuscript were written 
by JV with editing by MM. Statistical analysis methodology was developed 
by MM. Initial statistical analysis for meta-analysis purposes was performed 
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Ruth Foxlee of the Cochrane Wounds group developed the modified search 
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